• Make a Donation
  • Join Fifth Sense
  • A founding member of the Breakthrough Consortium for Olfactory Health
  • info@fifthsense.org.uk
  • en English▼
    X
    ar Arabiczh-CN Chinese (Simplified)zh-TW Chinese (Traditional)nl Dutchen Englishfr Frenchde Germaniw Hebrewit Italianpt Portuguesepa Punjabiru Russianes Spanishvi Vietnamesecy Welsh
logotype
An open-label controlled trial of theophylline for treatment of patients with hyposmia
Home Document Respository An open-label controlled trial of theophylline for treatment of patients with hyposmia

Characteristics of taste disorders

29 September 2021

Smell in Covid-19 and Efficacy of Nasal Theophylline (SCENT2)

25 October 2021

Related Posts

Uncategorised
21 March 2019

Thanks for supporting our Development Plan application

By fifthsense
Uncategorised
27 February 2016

SmellTaste2017 – Florida, 25-26 February 2017

By fifthsense